This work investigated the functional role of
nuclear factor-kappaB (
NF-kappaB) in respiratory burst activity and in expression of the human phagocyte
nicotinamide adenine dinucleotide phosphate (
NADPH) oxidase genes CYBB, CYBA, NCF1, and NCF2. U937 cells with a stably transfected repressor of
NF-kappaB (
IkappaBalpha-S32A/S36A) demonstrated significantly lower
superoxide release and lower CYBB and NCF1 gene expression compared with control U937 cells. We further tested Epstein-Barr virus (EBV)-transformed B cells from patients with
anhidrotic ectodermal dysplasia with immunodeficiency (
EDA-ID), an inherited disorder of
NF-kappaB function.
Superoxide release and CYBB gene expression by
EDA-ID cells were significantly decreased compared with healthy cells and similar to cells from patients with
X-linked chronic granulomatous disease (X91(0) CGD). NCF1 gene expression in
EDA-ID S32I cells was decreased compared with healthy control cells and similar to that in autosomal recessive (A47(0)) CGD cells. Gel shift assays demonstrated loss of recombinant human p50 binding to a
NF-kappaB site 5' to the CYBB gene in U937 cells treated with
NF-kappaB inhibitors, repressor-transfected U937 cells, and
EDA-ID patients' cells.
Zymosan phagocytosis was not affected by transfection of U937 cells with the
NF-kappaB repressor. These studies show that
NF-kappaB is necessary for CYBB and NCF1 gene expression and activation of the phagocyte
NADPH oxidase in this model system.